To evaluate whether SGL 12 improved FFA-induced hepatic steatosis, expression of AMPK, PPARα, SREBP-1, FAS, and ACC—genes related to lipid metabolism—was evaluated. This evidence concerns the gene SREBF1 and Hepatic steatosis.